Trials / Completed
CompletedNCT06148259
SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes
Comparison of Two Novel Anti Diabetes Medications Classes as Regard Prostate Symptoms in Patient With Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Kasr El Aini Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to compare the effect of two different classes of anti- diabetes medications on prostate volume and symptoms in elderly patients with diabetes mellitus
Detailed description
The study aims to compare the effect of two different classes of anti- diabetes medications on prostate volume and symptoms in elderly patients with diabetes mellitus The study compares sodium glucose cotransporter 2 inhibitors to Dipeptidyl peptidase 4 inhibitors in elderly patients with type 2 diabetes mellitus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | International prostate symptom score | Questionnaire of 8 questions to be administered to all patients about prostate symptoms |
| DIAGNOSTIC_TEST | Assessment of prostate volume | Measurements using ultrasound |
| OTHER | Pittsburgh sleep quality Index | Questionnaire to assess quality of sleep |
| DIAGNOSTIC_TEST | Glycated hemoglobin | Measures control of diabetes |
Timeline
- Start date
- 2021-03-12
- Primary completion
- 2022-09-13
- Completion
- 2022-09-13
- First posted
- 2023-11-28
- Last updated
- 2023-11-28
Locations
2 sites across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06148259. Inclusion in this directory is not an endorsement.